Volume 9, Issue 1, February 2020, Page: 8-18
Effectiveness of Life Style Modification on Lipid Profile for Patients with Hyperlipidemia
Magda Moawad Mohsen, Community Health Nursing, Faculty of Nursing, Menoufia University, Al Minufya, Egypt
Neima Ali Riad, Medical-Surgical Nursing, Faculty of Nursing Menoufia University, Al Minufya, Egypt
Amina Ibrahim Badawy, Medical-Surgical Nursing, Faculty of Nursing Menoufia University, Al Minufya, Egypt
Badria Mahrous Abd El-Hammed, Medical-Surgical Nursing, Faculty of Nursing Menoufia University, Al Minufya, Egypt; Nursing Department, Faculty of Applied Medical Science, Al Baha University, Al Baha, Saudi Arabia
Dalia Mahmoud Abd Elmonem Elsherbini, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia; Department of Human Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Received: Dec. 9, 2019;       Accepted: Dec. 23, 2019;       Published: Jan. 4, 2020
DOI: 10.11648/j.ajns.20200901.12      View  133      Downloads  65
Abstract
Background: Major predisposing factors of Coronary artery diseases were urbanized lifestyles and growth of ageing populations in developing country like Egypt. The modifiable risk factors for cardiovascular disease (CVD) such as hyperlipidemia, diabetes mellitus, and obesity are likely to increase in the future, but they can be controlled through lifestyle modification. Aim of the study: This study was carried out to examine the effect of life style modification for patients with hyperlipidemia on their lipids profile. Design: Quasi experimental design was utilized. Setting This study was conducted among the patients attending at cardiac outpatient department, Menoufia University Hospital, Menoufia Governorate, Egypt. Subject: A purposive sample of 100 men and women attending cardiac outpatient clinic were selected. The subjects were divided equally into study and control groups. Instrumentations: a. Structured interview questionnaire: it consists of sociodemographic and medical data b. Bio-physiological measurement: Fasting venous blood samples for Glycosylated hemoglobin level, Lipid profile were obtained from all participants, and sent to biochemistry laboratories. Blood pressure assessment and BMI for all patients were compiled. Results: Statistical analysis showed that there were statistical differences among study and control group regard to total cholesterol, triglyceride, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol and their arterial blood pressure level. Conclusion: The need for tailoring and following up of intervention for coronary artery diseases is an essential maneuver to reduce their risk factors occurrence. Recommendations: Implementation of lifestyle modification for at risk patient for coronary artery diseases by modifying their lifestyle. Routine screening for all subjects above the age of forty to detect abnormal lipid profile early and to increase their awareness to prevent and control of cardiovascular disease (CVD) is recommended.
Keywords
Life Style Modification, Lipid Profile, Hyperlipidemia
To cite this article
Magda Moawad Mohsen, Neima Ali Riad, Amina Ibrahim Badawy, Badria Mahrous Abd El-Hammed, Dalia Mahmoud Abd Elmonem Elsherbini, Effectiveness of Life Style Modification on Lipid Profile for Patients with Hyperlipidemia, American Journal of Nursing Science. Vol. 9, No. 1, 2020, pp. 8-18. doi: 10.11648/j.ajns.20200901.12
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Rhee EJ, et al., (2019): 2018 Guidelines for the management of dyslipidemia. Korean J Intern Med. Jul; 34 (4): 723-771. doi: 10.3904/kjim.2019.188. Epub 2019 Jul 1. No PMID: 31272142.
[2]
Wiggins BS, Dixon D, Bellone J, Gasbarro N, Marrs JC, Tran R., (2019): Guidelines in the Management of Dyslipidemia: 2019 Update”. J Pharm Pract. Aug 11: 897190019868413. doi: 10.1177/0897190019868413. PMID: 31401932.
[3]
El-Moselhy et al., (2018). Coronary Artery Disease among Elderly Egyptian Patients: I. Socio-Demographic, Lifestyle, Psychosocial, Medical, and Biochemical Risk Factors. American Journal of Gerontology and Geriatrics, Volume 1, Issue 2, e1006.
[4]
Jellinger PS, et al., (2017): American Association Of Clinical Endocrinologists And American College Of Endocrinology Guidelines For Management Of Dyslipidemia And Prevention Of Cardiovascular Disease. Endocr Pract.; 23 (Suppl 2): 1-87. doi: 10.4158/EP171764.APPGL. PMID: 28437620.
[5]
Adhyaru BB, Jacobson TA., (2016): New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk: A Comparison of the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines with the 2014 National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia. Endocrinol Metab Clin North Am. 2016 Mar; 45 (1): 17-37. doi: 10.1016/j.ecl.2015.09.002. Review. PMID: 26892995.
[6]
Berman AN, Blankstein R., (2019) Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options. Curr Cardiol Rep.; 21 (9): 110. doi: 10.1007/s11886-019-1175-z. Review.PMID: 31378838.
[7]
World Health Organization, (2012). Cardiovascular diseases (CVDs) Fact sheet no. 317. Available from: http://www.who.int/mediacentre/factsheets/fs317/en/index.html.
[8]
United Nations. (2015) Transforming our world: the 2030 agenda for sustainable development.. https://www.un.org/ga/search/ view_doc.asp, symbol=A/RES/70/1&Lang=E (accessed July 26, 2019).
[9]
Roth GA, Abate D, Abate KH, et al. Global, (2018) regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet; 392: 1736–88.
[10]
WHO. HEARTS technical package. (2019). https://www.who.int/ publications-detail/hearts-technical-package.
[11]
Tips for Healthy lifestyle changes (modification) and Wellness (2017). https://www.jotscroll.com › forums › posts › healthy-lifestyle-change modification. American college of life style medicine https://lifestylemedicine.org/ACLM/Education/Board.
[12]
NICE Pathway, Cardio Vascular Disease Prevention, (2019) http://pathways.nice.org.uk/pathways/cardiovascular-disease-prevention.
[13]
Wilson PW., Polonsky TS., Miedema MD., Khera A., Kosinski AS., Kuvin JT., (2019) Systematic Review for the Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. Jun 25; 73 (24): 3210-3227. doi: 10.1016/j.jacc..11.004. PMID: 30423394.
[14]
Kundu, D., Saikia, M. & Paul, T. (2017). Study of the Correlation between Total Lipid Profile and Glycosylated Hemoglobin Among the Indigenous Population of Guwahati. Int. J. Life. Sci. Scienti. Res, 3, 1175-1180.
[15]
Singh, R. J., Kohli, K., Gupta, A. K., & Gupta, S. (2018). Hyperlipidemia: Treatment Modality And Busting Myths Of Dietary Approach.‏ World Journal of Pharmaceutical ResearchSJIF Volume 7, Issue 16, 395-406.
[16]
Arshad H, Iftikhar A, Waqar K and Fatima Y., (2019) Correlation between Body Mass Index and Lipid Profile in patients with Type 2 Diabetes attending a tertiary care hospital in Peshawar, Pak J Med Sci. May-Jun; 35 (3): 591–597. doi: 10.12669/pjms.35.3.7
[17]
Ettehad D, Emdin CA, Kiran A, et al., (2016) Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta- analysis. Lancet; 387: 957–967.
[18]
Patnode CD, Evans CV, Senger CA, Redmond N, Lin JS. (2019). Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].
[19]
Bei, Y., Zhou, Q., Sun, Q. & Xiao, J. (2015). Exercise as a platform for pharmacotherapy development in cardiac diseases. Current pharmaceutical design, 21, 4409-4416.
[20]
Lucas, J.-M. & Kozlowski, K. F. (2019). The Underutilization of Lifestyle Modifications in Primary Care Medicine. Exercise Medicine, 3, 3.
[21]
Sanin V, Koenig W. (2019) Therapy of Hypercholesterolemia in Primary Prevention. Dtsch Med Wochenschr. Mar; 144 (5): 322-328. doi: 10.1055/a-0657-1668. Epub. 5. Review. German. PMID: 30836403.
[22]
Yiyi Zhang et al., (2019) Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular EventsJournal of the American College of Cardiology Volume 74, Issue 3, DOI: 10.1016/j.jacc.2019.03.529.
[23]
Arnett DK, et al., (2019) ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10; 140 (11): e596-e646.
[24]
Lloyd-Jones DM, et al., (2017) Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2017 Oct 3; 70 (14): 1785-1822. doi: 10.1016/j.jacc.2017.07.745. Epub 2017 Sep 5. PMID: 28886926.
[25]
Chikwere, P. & Annan, R. A. (2016). Dietary habit and other lifestyles and serum lipid profile of type 2 diabetes patients: a systematic review. Nutrition & Food Science, 46, 161-170.
[26]
Weber C, Badimon L, Mach F, van der Vorst EPC. (2017) Therapeutic strategies for atherosclerosis and atherothrombosis: past, present and future. Thromb Haemost; 117: 1258–1264. Google Scholar
[27]
Ghanwat, G. H. & Sontakke, A. V. (2018). Effect of Vitamin C Supplementation on Anthropometric Measurements, Lipid Profile and Atherogenic Indices in Obese and Non Obese Individuals. Journal of Clinical & Diagnostic Research, 12.
[28]
Kelsey and Fleiss (2010). Methods in observational Epidemiology 2nd Edition, Statistical Methods for Rates and Proportion, formulas 3.18 and 19. Avaliable at: Epi website (Open Source Statistics for Public Health): http://www.openepi.com/SampleSize/SSCohort.htm.
[29]
Hartz, J. & Clauss, S. (2017). Treatment Strategies for Hypercholesterolemia. Current pediatric reviews, 13, 243-254.
[30]
Lubinskaya E., Protasov, E., and. Demchenko, E. (2016): The level of cardiovascular risk factors correction in patient undergoing myocardial revascularization, Symposium of the International Atherosclerosis Society June 2–4, 2016, St. Petersburg, Russia.
[31]
TURAN, T. N., et al., (2018). Relationship between risk factor control and compliance with a lifestyle modification program in the stenting aggressive medical management for prevention of recurrent stroke in intracranial stenosis trial. Journal of Stroke and Cerebrovascular Diseases, 27, 801-805.
[32]
Abess et al. (2017): Lipid Profile and Coronary Heart Disease. International journal of pharmacy & Pharmaceutical Research (ISSN 2349-7203), Vol.: 11, Issue: 1.
[33]
Al-Hassan, Y. T. & Fabella, E. L. (2017). Lipid profile analysis of patients in a saudi university clinic. Public Health International, 2, 89-95.
[34]
Blasco, A., et al., (2012). Evaluation of a telemedicine service for the secondary prevention of coronary artery disease. Journal of cardiopulmonary rehabilitation and prevention, 32 (1), 25-31.‏
[35]
Del Prato S, Nicolucci A, Lovagnini-Scher AC, Turco S, Leotta S, Vespasiani G: (2012) Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the Eleonor study. Diabetes Technol Ther, 14: 175-182. | Article | PubMed.
[36]
Gungar T, Karadakovan and Saygili F (2013). The use of videophone technology (telenursing) in the glycaemic control of diabetic patients: a randomized controlled trial. Journal of Diabetes Research & Clinical Metabolism, ISSN 2050-0866
[37]
Farkouh, M. E., et al., (2013). Risk factor control for coronary artery disease secondary prevention in large randomized trials. Journal of the American College of Cardiology, 61 (15), 1607-1615.‏
[38]
Beyazıt, E., & Mollaoğlu, M. (2011). Investigation of effect on glycosylated hemoglobin, blood pressure, and body mass index of diabetes intensive education program in patients with type 2 diabetes mellitus. American journal of men's health, 5 (4), 351-357.
[39]
Ibrahim, M. M., Ibrahim, A., Shaheen, K. & Nour, M. A. (2013). Lipid profile in Egyptian patients with coronary artery disease. The Egyptian Heart Journal, 65, 79-85.
[40]
Párraga-Martínez, I., et al., (2018). Efficacy of a Combined Strategy to Improve Low-density Lipoprotein Cholesterol Control among Patients With Hypercholesterolemia: A Randomized Clinical Trial. Revista Española de Cardiología (English Edition), 71 (1), 33-41.‏
[41]
Akwa, L. G., et al., (2017). Lipid profile, cardiorespiratory function and quality of life of postmenopausal women improves with aerobic exercise. Journal of Human Sport and Exercise, 12 (3), 698-709. doi: https://doi.org/10.14198/jhse.2017.123.14.
[42]
Wadden, T. A., Webb, V. L., Moran, C. H. & Bailer, B. A., (2012). Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation, 125, 1157-1170.
[43]
Cugnetto, M. L., Saab, P. G., Llabre, M. M., Goldberg, R., McCalla, J. R., & Schneiderman, N. (2008). Lifestyle factors, body mass index, and lipid profile in adolescents. Journal of pediatric psychology, 33 (7), 761-771.‏
[44]
Wood DA, Kotseva K, Connolly S, et al.; (2008) on behalf of Euroaction Study Group. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (Euroaction) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: A paired, cluster-randomised controlled trial. Lancet; 371: 1999–2012.
[45]
Rigotti NA, Munafo MR and Stead LF., (2008) Smoking cessation interventions for hospitalized smokers: A systematic review. Arch Intern Med; 168: 1950–1960.
[46]
Ammar, T., (2015). Effects of aerobic exercise on blood pressure and lipids in overweight hypertensive postmenopausal women. Journal of Exercise Rehabilitation, 11 (3), 145–150. http://doi.org/10.12965/jer.150204.
[47]
Kotseva, K., & Euroaspire Investigators. (2017). The Euroaspire Surveys: lessons learned in cardiovascular disease prevention. Cardiovascular diagnosis and therapy, 7 (6), 633.‏
[48]
Pogosova N., Kotseva K., De Bacquer D., et al., (2017) Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the Euroaspire IV Survey. A Registry From The European Society of Cardiology, on Behalf of The Euroaspire Investigators. Eur J Prev Cardiol. Epub ahead of print 23. DOI: 10.1177/ 2047487317711334.
Browse journals by subject